Pharmacological Effects of Glycyrrhiza Spp. and Its Bioactive Constituents: Update and Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma by Andrea Shergalis
Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma By Andrea Shergalis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medicinal Chemistry) in the University of Michigan 2020 Doctoral Committee: Professor Nouri Neamati, Chair Professor George A. Garcia Professor Peter J. H. Scott Professor Shaomeng Wang Andrea G. Shergalis [email protected] ORCID 0000-0002-1155-1583 © Andrea Shergalis 2020 All Rights Reserved ACKNOWLEDGEMENTS So many people have been involved in bringing this project to life and making this dissertation possible. First, I want to thank my advisor, Prof. Nouri Neamati, for his guidance, encouragement, and patience. Prof. Neamati instilled an enthusiasm in me for science and drug discovery, while allowing me the space to independently explore complex biochemical problems, and I am grateful for his kind and patient mentorship. I also thank my committee members, Profs. George Garcia, Peter Scott, and Shaomeng Wang, for their patience, guidance, and support throughout my graduate career. I am thankful to them for taking time to meet with me and have thoughtful conversations about medicinal chemistry and science in general. From the Neamati lab, I would like to thank so many. First and foremost, I have to thank Shuzo Tamara for being an incredible, kind, and patient teacher and mentor. Shuzo is one of the hardest workers I know. In addition to a strong work ethic, he taught me pretty much everything I know and laid the foundation for the article published as Chapter 3 of this dissertation. The work published in this dissertation really began with the initial identification of PDI as a target by Shili Xu, and I am grateful for his advice and guidance (from afar!). -
Hazard Assessment of Glycyrrhizic Acid from Liquorice
VKM Report 2018: 09 Hazard assessment of glycyrrhizic acid from liquorice Opinion of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian Scientific Committee for Food and Environment Report from the Norwegian Scientific Committee for Food and Environment (VKM) 2018: 09 Hazard assessment of glycyrrhizic acid from liquorice Opinion of Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian Scientific Committee for Food and Environment 08.05.2018 ISBN: 978-82-8259-306-9 ISSN: 2535-4019 Norwegian Scientific Committee for Food and Environment (VKM) Po 4404 Nydalen N – 0403 Oslo Norway Phone: +47 21 62 28 00 Email: [email protected] vkm.no vkm.no/English Cover photo: ColourBox Suggested citation: VKM, Inger-Lise Steffensen, Gro Haarklou Mathisen, Ellen Bruzell, Berit Brunstad Granum, Jens Rohloff, Ragna Bogen Hetland (2018) Hazard assessment of glycyrrhizic acid from liquorice. Opinion of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics. ISBN: 978-82-8259-306-9. Norwegian Scientific Committee for Food and Environment (VKM), Oslo, Norway. VKM Report 2018: 09 Hazard assessment of glycyrrhizic acid from liquorice Preparation of the opinion The Norwegian Scientific Committee for Food and Environment (Vitenskapskomiteen for mat og miljø, VKM) appointed a project group to answer the request from the Norwegian Food Safety Authority. The project group consisted of two VKM members of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics and a project leader from the VKM secretariat. -
Natural Chalcones in Chinese Materia Medica: Licorice
Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2020, Article ID 3821248, 14 pages https://doi.org/10.1155/2020/3821248 Review Article Natural Chalcones in Chinese Materia Medica: Licorice Danni Wang ,1 Jing Liang,2 Jing Zhang,1 Yuefei Wang ,1 and Xin Chai 1 1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China 2School of Foreign Language, Chengdu University of Traditional Chinese Medicine, Sichuan 611137, China Correspondence should be addressed to Xin Chai; [email protected] Received 28 August 2019; Accepted 7 February 2020; Published 15 March 2020 Academic Editor: Veronique Seidel Copyright © 2020 Danni Wang et al. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Licorice is an important Chinese materia medica frequently used in clinical practice, which contains more than 20 triterpenoids and 300 flavonoids. Chalcone, one of the major classes of flavonoid, has a variety of biological activities and is widely distributed in nature. To date, about 42 chalcones have been isolated and identified from licorice. -ese chalcones play a pivotal role when licorice exerts its pharmacological effects. According to the research reports, these compounds have a wide range of biological activities, containing anticancer, anti-inflammatory, antimicrobial, antioxidative, antiviral, antidiabetic, antidepressive, hep- atoprotective activities, and so on. -is review aims to summarize structures and biological activities of chalcones from licorice. We hope that this work can provide a theoretical basis for the further studies of chalcones from licorice. -
Biotransformation of Hydroxychalcones As a Method of Obtaining Novel and Unpredictable Products Using Whole Cells of Bacteria
catalysts Article Biotransformation of Hydroxychalcones as a Method of Obtaining Novel and Unpredictable Products Using Whole Cells of Bacteria Joanna Kozłowska 1,* , Bartłomiej Potaniec 1,2 and Mirosław Anioł 1 1 Department of Chemistry, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland; [email protected] (B.P.); [email protected] (M.A.) 2 Łukasiewicz Research Network—PORT Polish Center for Technology Development, Stabłowicka 147, 54-066 Wrocław, Poland * Correspondence: [email protected] Received: 27 September 2020; Accepted: 8 October 2020; Published: 12 October 2020 Abstract: The aim of our study was the evaluation of the biotransformation capacity of hydroxychalcones—2-hydroxy-40-methylchalcone (1) and 4-hydroxy-40-methylchalcone (4) using two strains of aerobic bacteria. The microbial reduction of the α,β-unsaturated bond of 2-hydroxy-40- methylchalcone (1) in Gordonia sp. DSM 44456 and Rhodococcus sp. DSM 364 cultures resulted in isolation the 2-hydroxy-40-methyldihydrochalcone (2) as a main product with yields of up to 35%. Additionally, both bacterial strains transformed compound 1 to the second, unexpected product of reduction and simultaneous hydroxylation at C-4 position—2,4-dihydroxy-40-methyldihydrochalcone (3) (isolated yields 12.7–16.4%). During biotransformation of 4-hydroxy-40-methylchalcone (4) we observed the formation of three products: reduction of C=C bond—4-hydroxy-40-methyldihydrochalcone (5), reduction of C=C bond and carbonyl group—3-(4-hydroxyphenyl)-1-(4-methylphenyl)propan-1-ol (6) and also unpredictable 3-(4-hydroxyphenyl)-1,5-di-(4-methylphenyl)pentane-1,5-dione (7). -
Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy in Vitro and in Vivo
1521-0111/96/5/589–599$35.00 https://doi.org/10.1124/mol.119.116129 MOLECULAR PHARMACOLOGY Mol Pharmacol 96:589–599, November 2019 Copyright ª 2019 by The American Society for Pharmacology and Experimental Therapeutics Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo Zhi-Xing Cao,1 Yi Wen,1 Jun-Lin He, Shen-Zhen Huang, Fei Gao, Chuan-Jie Guo, Qing-Qing Liu, Shu-Wen Zheng, Dao-Yin Gong, Yu-Zhi Li, Ruo-Qi Zhang, Jian-Ping Chen, and Cheng Peng Pharmacy College, Chengdu University of Traditional Chinese Medicine, Ministry of Education Key Laboratory of Standardization Downloaded from of Chinese Herbal Medicine, Key Laboratory of Systematic Research, Development and Utilization of Chinese Medicine Resources in Sichuan Province-Key Laboratory Breeding Base of Co-founded by Sichuan Province and MOST, Chengdu, China (Z.-X.C., J.-L.H., C.-J.G., S.-W.Z., D.-Y.G., Y.-Z.L., R.-Q.Z., J.-P.C., C.P.);School of Chinese Medicine, University of Hong Kong, Hong Kong, China (Y.W., F.G., Q.-Q.L., J.-P.C.); College, Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen, China (Y.W., F.G., Q.-Q.L., J.-P.C.); and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China (S.-Z.H.) molpharm.aspetjournals.org Received February 19, 2019; accepted August 20, 2019 ABSTRACT Licorice is a medicinal herb widely used to treat inflammation- AML cells. -
Belgian Week of Gastroenterology 2019 Belgian Association for The
Belgian Week of Gastroenterology 2019 http://www.bwge.be Belgian Association for the Study of the Liver (BASL) / Belgian Liver Intestine Committee (BLIC) A01 The sPDGFR-beta containing PRTA-score is a novel diagnostic algorithm for significant liver fibrosis in patients with viral, alcoholic, and metabolic liver disease J. LAMBRECHT (1), S. VERHULST (1), I. MANNAERTS (1), J. SOWA (2), J. BEST (2), A. CANBAY (2), H. REYNAERT (1), L. VAN GRUNSVEN (1) / [1] Vrije Universiteit Brussel (VUB), Jette, Belgium, Department of Basic Biomedical Sciences, Liver Cell Biology Laboratory, [2] University Hospital Magdeburg, , Germany, Department of Gastroenterology, Hepatology and Infectious Diseases Introduction: Diagnosis of liver fibrosis onset and regression remains a controversial subject in the current clinical setting, as the gold standard remains the invasive liver biopsy. Multiple novel non-invasive markers have been proposed but lack sufficient sensitivity and specificity for diagnosis of early stage liver fibrosis. Platelet Derived Growth Factor Receptor beta (PDGFRβ) has been associated to hepatic stellate cell activation and has been the target of multiple therapeutic studies. However, little is known concerning its use as a diagnostic agent. Aim: In this study, we analysed the diagnostic potential of PDGFRβ for liver fibrosis in a heterogenous patient population. Methods: The study cohort consisted of 148 patients with liver fibrosis/cirrhosis due to various causes of liver injury (metabolic, alcoholic, viral), and 14 healthy individuals as control population. A validation cohort of 57 patients with metabolic liver disease, who underwent liver biopsy to stage fibrosis, were gathered. Circulating soluble PDGFRβ (sPDGFRβ) levels were determined using a commercial ELISA kit. -
Biosynthesis of Food Constituents: Natural Pigments. Part 2 – a Review
Czech J. Food Sci. Vol. 26, No. 2: 73–98 Biosynthesis of Food Constituents: Natural Pigments. Part 2 – a Review Jan VELÍšEK, Jiří DAVÍDEK and Karel CEJPEK Department of Food Chemistry and Analysis, Faculty of Food and Biochemical Technology, Institute of Chemical Technology in Prague, Prague, Czech Republic Abstract Velíšek J., Davídek J., Cejpek K. (2008): Biosynthesis of food constituents: Natural pigments. Part 2 – a review. Czech J. Food Sci., 26: 73–98. This review article is a part of the survey of the generally accepted biosynthetic pathways that lead to the most impor- tant natural pigments in organisms closely related to foods and feeds. The biosynthetic pathways leading to xanthones, flavonoids, carotenoids, and some minor pigments are described including the enzymes involved and reaction schemes with detailed mechanisms. Keywords: biosynthesis; xanthones; flavonoids; isoflavonoids; neoflavonoids; flavonols; (epi)catechins; flavandiols; leu- coanthocyanidins; flavanones; dihydroflavones; flavanonoles; dihydroflavonols; flavones; flavonols; anthocya- nidins; anthocyanins; chalcones; dihydrochalcones; quinochalcones; aurones; isochromenes; curcuminoids; carotenoids; carotenes; xanthophylls; apocarotenoids; iridoids The biosynthetic pathways leading to the tetrapyr- restricted in occurrence to only a few families of role pigments (hemes and chlorophylls), melanins higher plants and some fungi and lichens. The (eumelanins, pheomelanins, and allomelanins), majority of xanthones has been found in basi- betalains (betacyanins and betaxanthins), and cally four families of higher plants, the Clusiaceae quinones (benzoquinones, naphthoquinones, and (syn. Guttiferae), Gentianaceae, Moraceae, and anthraquinones) were described in the first part of Polygalaceae (Peres et al. 2000). Xanthones can this review (Velíšek & Cejpek 2007b). This part be classified based on their oxygenation, prenyla- deals with the biosynthesis of other prominent tion and glucosylation pattern. -
RIVM Report 340630001 the Health and Addiction Risk of the Glycyrrhizic
RIVM report 340630001/2003 The health and addiction risk of the glycyrrhizic acid component of liquorice root used in tobacco products I. van Andel, G. Wolterink, G. van de Werken, H. Stevenson, L.A.G.J.M. van Aerts, and W. Vleeming This investigation is carried out for the account of the Directorate for Public Health of the Ministry of Health, Welfare and Sports and of the Inspectorate for Health Protection and Veterinary Public Health, within the framework of project 340630 RIVM, P.O. Box 1, 3720 BA Bilthoven, telephone: 31 - 30 - 274 91 11; telefax: 31 - 30 - 274 29 71 RIVM report 340630001 page 2 of 35 Abstract Reported here is the evaluation of the health effects and possible addictive effects of liquorice preparations as a conditioning and flavouring agent in tobacco products. Based on the literature survey, the evaluation describes the exposure to, and the pharmacology, pharmacokinetics and toxicology of glycyrrhizic acid, the main biologically active component of liquorice preparations. The report also goes into the addictive aspects of glycyrrhizic acid. The level of glycyrrhizic acid in cigarette smoke or in tobacco products is not known. Furthermore, it is improbable that the intake of glycyrrhizic acid during cigarette smoking will exceed the daily oral intake. A point of concern is the nature of the combustion products formed during cigarette smoking. It is unlikely that smoking-related exposure to glycyrrhizic acid will increase mineralocorticoid activity and result under some conditions in hypertension. The statement that glycyrrhizic acid acts as a bronchodilatator could not be confirmed from the currently available literature. -
In Vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in 2 COVID-19 3
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.29.424728; this version posted December 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 In vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in 2 COVID-19 3 4 Clarissa S. Santoso1, Zhaorong Li2, Jaice T. Rottenberg1, Xing Liu1, Vivian X. Shen1, Juan I. 5 Fuxman Bass1,2 6 7 1Department of Biology, Boston University, Boston, MA 02215, USA; 2Bioinformatics Program, 8 Boston University, Boston, MA 02215, USA 9 10 Corresponding author: 11 Juan I. Fuxman Bass 12 Boston University 13 5 Cummington Mall 14 Boston, MA 02215 15 Email: [email protected] 16 Phone: 617-353-2448 17 18 Classification: Biological Sciences 19 20 Keywords: COVID-19, cytokine release syndrome, cytokine storm, drug repurposing, 21 transcriptional regulators 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.29.424728; this version posted December 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 22 Abstract 23 Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing 24 hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators 25 of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription 26 factors (TFs) for therapeutic targeting using approved drugs. -
WO 2017/131957 Al 3 August 2017 (03.08.2017) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/131957 Al 3 August 2017 (03.08.2017) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 8/35 (2006.01) A61Q 5/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 8/97 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, (21) International Application Number: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2017/012985 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (22) International Filing Date: KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, 11 January 2017 ( 11.01 .2017) MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (25) Filing Language: English RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, (26) Publication Language: English TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/287,501 27 January 2016 (27.01.2016) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: ELC MANAGEMENT LLC [US/US]; 155 GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, Pinelawn Road, Suite 345 South, Melville, New York TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, 11747 (US). -
PROTOCOL GOG-3007 (Clinicaltrials.Gov NCT02228681)
Philip J. DiSaia, M.D. Larry J. Copeland, M.D. Group Chair Group Vice Chair Administrative Office Finance/Development Office Four Penn Center 2127 Espey Court 1600 John F. Kennedy Boulevard, Suite 1020 Suite 100 Philadelphia, Pennsylvania 19103 Crofton, Maryland 21114 Phone: 215-854-0770 Fax: 215-854-0716 Phone: 410-721-7126 Fax: 301-261-3972 Laura L. Reese Mary C. Sharp Executive Director of Operations Chief Financial Officer PROTOCOL GOG-3007 (ClinicalTrials.gov NCT02228681) A RANDOMIZED PHASE II TRIAL OF EVEROLIMUS AND LETROZOLE OR HORMONAL THERAPY (TAMOXIFEN/MEDROXYPROGESTERONE ACETATE) IN WOMEN WITH ADVANCED, PERSISTENT, OR RECURRENT ENDOMETRIAL CARCINOMA SPONSOR: GOG FOUNDATION, INC. IND EXEMPT Version Date: June 25, 2015 STUDY CHAIR NURSE CONTACT BRIAN M. SLOMOVITZ, M.D. NANCY FUSCO, CCRP SYLVESTER COMPREHENSIVE CANCER CTR UNIVERSITY HOSPITALS U MIAMI MILLER SCHOOL OF MED CASE MEDICAL CENTER 1475 NW 12 AVE, SUITE 3500 DEPT GYN/ONC MIAMI, FL 33136 11100 EUCLID AVE (305) 243-2233 CLEVELAND OH 44106 216 844 1661 FAX: (305) 243-4938 FAX: 216-844- 8596 E-MAIL: [email protected] E-MAIL: [email protected] STUDY CO-CHAIR ROBERT L. COLEMAN, M.D. See GOG Website directory TRANSLATIONAL RESEARCH CO-CHAIR PATHOLOGIST KAREN H. LU, M.D. ELIZABETH D. EUSCHER, MD See GOG Website Directory See GOG Website Directory TRANSLATONAL RESEARCH SCIENTIST STATISTICIAN HEATHER A LANKES, PhD, MPH VIRGINIA FILIACI, PhD See GOG Website Directory See GOG Website Directory This protocol was designed and developed by the GOG and Novartis. It is intended to be used only in conjunction with institution-specific IRB approval for study entry. -
Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?
biomolecules Review Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? Luisa Diomede 1,* , Marten Beeg 1, Alessio Gamba 2 , Oscar Fumagalli 1, Marco Gobbi 1 and Mario Salmona 1,* 1 Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy; [email protected] (M.B.); [email protected] (O.F.); [email protected] (M.G.) 2 Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy; [email protected] * Correspondence: [email protected] (L.D.); [email protected] (M.S.) Abstract: The phytotherapeutic properties of Glycyrrhiza glabra (licorice) extract are mainly attributed to glycyrrhizin (GR) and glycyrrhetinic acid (GA). Among their possible pharmacological actions, the ability to act against viruses belonging to different families, including SARS coronavirus, is particularly important. With the COVID-19 emergency and the urgent need for compounds to counteract the pandemic, the antiviral properties of GR and GA, as pure substances or as components of licorice extract, attracted attention in the last year and supported the launch of two clinical trials. In silico docking studies reported that GR and GA may directly interact with the key players in viral internalization and replication such as angiotensin-converting enzyme 2 (ACE2), spike protein, the host transmembrane serine protease 2, and 3-chymotrypsin-like cysteine protease. In vitro data indicated that GR can interfere with virus entry by directly interacting with ACE2 and spike, with a nonspecific effect on cell and viral membranes.